News

Sleep Better Columbus is now offering FDA-cleared oral appliance therapy for patients diagnosed with mild to moderate ...
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
Ochsner Baton Rouge is now offering the FDA-approved Inspire device, a small implant that can be implanted in the body to ...
Topline data were announced from a phase 3 trial evaluating AD109 (aroxybutynin 2.5mg/atomoxetine 75mg) in participants with obstructive sleep apnea.
Many Americans are chronically sleep deprived, whether they suffer from insomnia or sleep apnea or are just not able to clock enough hours in bed. The Centers for Disease Control and ...
Obstructive Sleep Apnea (OSA) remains a widespread yet under-treated condition, affecting millions globally. Traditional treatments such as CPAP therapy, w | Drug Discovery And Development ...
Analysts expect a negative impact on ResMed Inc. (RMD) after privately held pharmaceutical company and rival Apnimed, Inc.
The FDA-cleared EnsoSleep PPG home sleep test now features position data captured by Advanced Brain Monitoring’s Night Shift sleep positioner ...
A Cedar Rapids-based ear, nose and throat surgeon is among the first in the country – and the only in the Midwest – to offer ...
Apnimed has announced positive topline results from its pivotal Phase 3 SynAIRgy clinical trial evaluating the efficacy and safety of AD109 in adults living with mid, moderate and severe OSA and acros ...
What's claimed to be the largest study of medical cannabis and obstructive sleep apnea finds a significant improvement in ...
At Home Sleep Apnea Testing has released a new guide detailing modern advancements in sleep apnea testing and highlighting ...